Data as of Oct 21
| +0.25 / +5.17%|
The 1 analysts offering 12-month price forecasts for Northwest Biotherapeutics Inc have a median target of 15.10, with a high estimate of 15.10 and a low estimate of 15.10. The median estimate represents a +196.66% increase from the last price of 5.09.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.